TOFANIR-5MG (Tofacitinib (5mg))

TOFANIR 5mg Tablet is indicated for managing moderate to severe cases of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication works by alleviating pain, tenderness, and swelling in the joints through its anti-inflammatory properties. Additionally, it contributes to slowing down the deterioration of bone and joint structures. The administration of TOFANIR 5mg may occur as a stand-alone treatment or in conjunction with other medications, depending on the specific needs of the patient. These tablets can be ingested with food or on an empty stomach, but it is recommended to take them consistently at the same time each day. The prescribed dosage will be tailored based on the individual’s condition and any other medications being taken. It is essential to follow your healthcare provider’s instructions regarding the use of this medication and to refrain from discontinuing it without medical advice, as this could lead to a worsening of your health status. It is crucial to undergo blood tests before initiating treatment, and this medication should not be started if there is an active infection. Discuss your medical history with your doctor, particularly if you have a history of tuberculosis, shingles, kidney or liver conditions, hepatitis B or C, or previous blood clots. TOFANIR 5mg may increase the risk of infections or exacerbate existing infections, so it is wise to limit exposure to individuals with contagious illnesses. This medication is not recommended for individuals under 18 years of age and should generally be avoided during pregnancy or lactation unless a healthcare professional assesses that the benefits outweigh the potential risks. Regular medical evaluations may be necessary during treatment.